Innovation & Research
Monday, November 23, 2020
Experts from the Swanson School of Engineering, the School of Computing and Information and the Institute for Cyber Law, Policy, and Security join a new consortium to produce methods, standards and tools to address complex cybersecurity vulnerabilities in manufacturing.
Tuesday, November 17, 2020
On Monday, Moderna became the second company to announce promising early results of its Phase 3 COVID-19 vaccine trial. The Pittsburgh site, led by Pitt’s Judy Martin, has seen more than 250 Pittsburghers roll up their sleeves to volunteer.
Friday, November 13, 2020
When sushi rice is compressed, it sticks to the food it surrounds. A new study from Pitt engineers has found the same can be said for the mechanical properties of mucus.
Thursday, November 12, 2020
A nonpartisan team led by Leslie Marshall in Pitt’s Center for Sustainable Business has created a roadmap for climate-friendly industrial growth over the next decade to add jobs and economic prospects across the Ohio Valley.
Monday, November 9, 2020
Pitt Experts Optimistic About Vaccine Candidate’s Efficacy, Advise People Continue Protecting Themselves
Four Pitt experts offer their thoughts on Pfizer’s announcement today of a vaccine that early data show is more than 90% effective in preventing COVID-19.
Thursday, November 5, 2020
Research published today in Science describes a new method to extract tiny but extremely powerful antibody fragments from llamas, which could then be fashioned into inhalable therapeutics for COVID-19. Tune in today at 3 p.m. EST for a press conference on the findings.
Friday, October 16, 2020
It’s only fair that the Pitt Innovation Challenge would itself need to innovate. Find out which projects won this year’s competition—which awarded nearly $500,000—and how participants adjusted to a virtual event.
Friday, October 16, 2020
If you missed yesterday’s panel discussion on rolling out a vaccine for COVID-19, watch the recording here, or read highlights from a wide-ranging discussion.
Thursday, October 15, 2020
Pitt’s Jonas Salk Chair for Vaccine Research explains why we need multiple candidate vaccines, what’s special about SARS-CoV-2 and why he’s hopeful about the future.
Wednesday, October 14, 2020
When Jonas Salk and his Pitt team, supported by March of Dimes, tackled the polio pandemic, they came up with creative ways to make and distribute the vaccine. Dr. Rahul Gupta of March of Dimes explains why that sort of approach is needed to eradicate COVID-19 today.